BKD Stock Analysis: Brookdale Senior Living | NYSE

Medical Care Facilities | NYSE, USA | Market Cap: 3.790m USD | 12M Return: 86.2% | Charts, Fundamentals & Technical Analysis

Independent Living, Assisted Living, Memory Care, Retirement Communities

Total Rating 49

Safety 28

Buy Signal 0.86

Medical Care Facilities
Industry Rotation: +11.6

Market Cap: 3.79B
Avg Turnover: 63.6M

Risk 3d forecast

Volatility52.7%

VaR 5^th Pctl7.87%

VaR vs Median-7.62%

Reward TTM

Sharpe Ratio1.69

Rel. Str. IBD85.9

Rel. Str. Peer Group75

Character TTM

Beta0.185

Beta Downside-0.018

Hurst Exponent0.606

Drawdowns 3y

Max DD43.55%

CAGR/Max DD1.31

CAGR/Mean DD4.52

EPS (Earnings per Share)

Last SUE: 0.66
Qual. Beats: 0

Revenue

Rev. CAGR: 3.83%
Rev. Trend: 97.7%

Last SUE: -0.17
Qual. Beats: 0

Warnings

Negative Equity With Losses: Insolvent Profile

High Debt/EBITDA With Thin Interest Coverage

Interest Coverage Ratio Critical

Beneish M-Score Likely Earnings Manipulation

Altman Z'' In Financial Distress Zone

Tailwinds

Idiosyncratic Leader

Confidence

Seasonality 10.5 years of data

Jan +6.2% 12

Feb +2.4% 16

Mar -0.4% 22

Apr +2.0% 11

May -0.1% 5

Jun +10.1% 29

Jul +5.2% 10

Aug +0.1% 5

Sep -4.0% 36

Oct -1.0% 19

Nov -0.1% 8

Dec -8.4% 27

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: BKD Brookdale Senior Living

Brookdale Senior Living Inc. (NYSE: BKD) is a U.S.-based operator of senior living communities organized into three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). Its communities serve a range of resident needs, from largely autonomous middle-to-upper income seniors to those requiring 24-hour assistance with daily living, specialized Alzheimers and dementia care, and skilled nursing services. Brookdale also manages communities on behalf of third-party owners. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.

Within the Health Care Facilities sub-industry, senior living operators like Brookdale generate revenue primarily through monthly resident fees for housing, personal care, and ancillary health services, with occupancy rates and the mix of acuity-level care serving as key performance drivers. A hybrid ownership-leasing model, combined with third-party management contracts, is a common structural feature across the sector, allowing operators to scale without bearing the full capital cost of property ownership.

Headlines to Watch Out For

Senior living occupancy recovery accelerates same-store revenue
Labor cost inflation pressures operating margins
Sale-leaseback transactions accelerate debt reduction

Piotroski VR-10 (Strict) 2.5

Net Income: -204.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.29 > 1.0
NWC/Revenue: 12.60% < 20% (prev -3.37%; Δ 15.98% < -1%)
CFO/TA 0.04 > 3% & CFO 215.5m > Net Income -204.6m
Net Debt (6.45b) to EBITDA (389.1m): 16.58 < 3
Current Ratio: 3.44 > 1.5 & < 3
Outstanding Shares: last quarter (238.1m) vs 12m ago 3.22% < -2%
Gross Margin: 14.32% > 18% (prev 27.40%; Δ -13.08% > 0.5%)
Asset Turnover: 51.39% > 50% (prev 48.60%; Δ 2.79% > 0%)
Interest Coverage Ratio: 0.19 > 6 (EBIT TTM 47.3m / Interest Expense TTM 253.7m)

Altman Z'' -1.90

A: 0.07 (Total Current Assets 552.5m - Total Current Liabilities 160.6m) / Total Assets 5.90b
B: -0.73 (Retained Earnings -4.31b / Total Assets 5.90b)
C: 0.01 (EBIT TTM 47.3m / Avg Total Assets 6.05b)
D: -0.01 (Book Value of Equity -55.9m / Total Liabilities 5.95b)
Altman-Z'' = -1.90 = D

Beneish M -0.42

DSRI: 1.08 (Receivables 64.4m/57.9m, Revenue 3.11b/3.02b)
GMI: 1.91 (GM 27.40% / 14.32%)
AQI: 3.86 (AQ_t 0.06 / AQ_t-1 0.02)
SGI: 1.03 (Revenue 3.11b / 3.02b)
TATA: -0.07 (NI -204.6m - CFO 215.5m) / TA 5.90b)
Beneish M = -0.42 (Cap -4..+1) = D

What is the price of BKD shares?

As of July 11, 2026, the stock is trading at USD 14.41 with a total of 11,735,265 shares traded. Over the past week, the price has changed by -9.20%, over one month by +10.00%, over three months by +6.35% and over the past year by +86.18%.

Current recommended Stop Loss: 13.70 (which is 4.9% or 1.2 ATR below the current price).

Is BKD a buy, sell or hold?

Brookdale Senior Living has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold BKD.

StrongBuy: 2
Buy: 1
Hold: 1
Sell: 1
StrongSell: 0

What are the forecasts/targets for the BKD price?

Analysts Target Price	19.6	35.9%

Brookdale Senior Living (BKD) - Fundamental Data Overview as of 05 July 2026

Market Cap USD = 3.79b (3.79b USD * 1.0 USD.USD)
P/E Forward = 38.1679
P/S = 1.2628
P/B = 20.531
P/EG = 0.2804
Revenue TTM = 3.11b USD
EBIT TTM = 47.3m USD
EBITDA TTM = 389.1m USD
Long Term Debt = 4.22b USD (from longTermDebt, last quarter)
Short Term Debt = 160.6m USD (from shortTermDebt, last quarter)
Debt = 6.72b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.21b
Net Debt = 6.45b USD (calculated: Debt 6.72b - CCE 270.1m)
Enterprise Value = 10.2b USD (3.79b + Debt 6.72b - CCE 270.1m)
Interest Coverage Ratio = 0.19 (Ebit TTM 47.3m / Interest Expense TTM 253.7m)
EV/FCF = 1000.0x (Enterprise Value 10.2b / FCF TTM 9.32m)
FCF Yield = 0.09% (FCF TTM 9.32m / Enterprise Value 10.2b)
FCF Margin = 0.30% (FCF TTM 9.32m / Revenue TTM 3.11b)
Net Margin = -6.58% (Net Income TTM -204.6m / Revenue TTM 3.11b)
Gross Margin = 14.32% ((Revenue TTM 3.11b - Cost of Revenue TTM 2.66b) / Revenue TTM)
Gross Margin QoQ = 3.33% (prev -1.18%)
Tobins Q-Ratio = 1.74 (Enterprise Value 10.2b / Total Assets 5.90b)
Interest Expense / Debt = 3.77% (Interest Expense 253.7m / Debt 6.72b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 37.4m (EBIT 47.3m * (1 - 21.00%))
Current Ratio = 3.44 (Total Current Assets 552.5m / Total Current Liabilities 160.6m)
Debt / Equity = -120.2 (out of range, set to none) (Debt 6.72b / totalStockholderEquity, last quarter -55.9m)
Debt / EBITDA = 16.58 (Net Debt 6.45b / EBITDA 389.1m)
Debt / FCF = 692.2 (Net Debt 6.45b / FCF TTM 9.32m)
Total Stockholder Equity = -510k (last 4 quarters mean from totalStockholderEquity)
RoA = -3.38% (Net Income -204.6m / Total Assets 5.90b)
RoE = 40.1k% (out of range, set to none) (Net Income TTM -204.6m / Total Stockholder Equity -510k)
RoCE = 1.12% (EBIT 47.3m / Capital Employed (Equity -510k + L.T.Debt 4.22b))
RoIC = 0.65% (NOPAT 37.4m / Invested Capital 5.74b)
WACC = 4.30% (E(3.79b)/V(10.5b) * Re(6.63%) + D(6.72b)/V(10.5b) * Rd(3.77%) * (1-Tc(0.21)))
Discount Rate = 6.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 93.21 | Cagr: 2.53%
[DCF] Terminal Value 75.44% ; FCFF base≈9.32m ; Y1≈9.36m ; Y5≈9.92m
[DCF] Fair Price = N/A (negative equity: EV 154.2m - Net Debt 6.45b = -6.30b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.66 | # QB: 0
Revenue Correlation: 97.71 | Revenue CAGR: 3.83% | SUE: -0.17 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.05 | Chg30d=+41.18% | Revisions=-25% | Analysts=3
EPS next Quarter (2026-09-30): EPS=-0.02 | Chg30d=+61.17% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=-0.14 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+81.1% | GrowthRev=-6.4%
EPS next Year (2027-12-31): EPS=0.15 | Chg30d=N/A | Revisions=+25% | GrowthEPS=+209.5% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +29% (up=3, down=1)